TURENNE ANDRE (President & CEO) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2021ACC: 0001104659-21-025278
DirectorOfficer· President & CEO
Since Jul 2018
+283K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
283K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+94K
Price / share
—
Trade value
—
% of position
63.4%
2/16/2021
148.38K→242.38K
Total
Net shares
+94K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2021 | A · Award | +94K | — | — | 63.4% | 148.38K | 242.38K |
| Total | +94K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
189K shares
Shares
+189K
Strike price
7.33
Held after
189K
Exercisable
—
2/16/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock189K shares | 2/16/2021 | A · Award | +189K | 7.33 | — | 189K |